Sean Dodge
Stock Analyst at RBC Capital
(2.93)
# 1,643
Out of 4,749 analysts
144
Total ratings
37.96%
Success rate
0.86%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $10.16 | +18.11% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $199.08 | +32.11% | 2 | Jan 15, 2025 | |
| HCAT Health Catalyst | Maintains: Sector Perform | $9 → $7 | $5.63 | +24.33% | 9 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $10.45 | +62.68% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $28.46 | +12.44% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $5.55 | +8.11% | 11 | Jan 8, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $201.36 | +34.09% | 5 | Dec 11, 2024 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $110.42 | -4.91% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $13.71 | +24.00% | 10 | Nov 21, 2024 | |
| AGL agilon health | Reiterates: Outperform | $3 | $3.34 | -10.18% | 6 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $40.19 | -15.40% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $12 → $13 | $12.48 | +0.16% | 14 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $24.82 | -43.59% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $4.77 | +109.64% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $22.85 | +22.54% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $11.09 | +26.24% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $149.25 | -77.89% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $1.68 | +10,614.29% | 2 | Mar 9, 2022 |
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $10.16
Upside: +18.11%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $199.08
Upside: +32.11%
Health Catalyst
Jan 15, 2025
Maintains: Sector Perform
Price Target: $9 → $7
Current: $5.63
Upside: +24.33%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $10.45
Upside: +62.68%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $28.46
Upside: +12.44%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $5.55
Upside: +8.11%
IQVIA Holdings
Dec 11, 2024
Reiterates: Outperform
Price Target: $270
Current: $201.36
Upside: +34.09%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $110.42
Upside: -4.91%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $13.71
Upside: +24.00%
agilon health
Nov 19, 2024
Reiterates: Outperform
Price Target: $3
Current: $3.34
Upside: -10.18%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $40.19
Upside: -15.40%
Nov 7, 2024
Downgrades: Sector Perform
Price Target: $12 → $13
Current: $12.48
Upside: +0.16%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $24.82
Upside: -43.59%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $4.77
Upside: +109.64%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $22.85
Upside: +22.54%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $11.09
Upside: +26.24%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $149.25
Upside: -77.89%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $1.68
Upside: +10,614.29%